Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Spanish eTIPS for Early Therapy in Perinatal Stroke (eTIPS-ES)

18 mai 2026 mis à jour par: University of Castilla-La Mancha

Spanish eTIPS: Translation, Cross-Cultural Adaptation, and Pilot Randomized Feasibility Study of Early Therapy in Perinatal Stroke for Spanish-Speaking Families

This study adapts and evaluates the Spanish version of eTIPS, an early home-based therapy program for infants at risk of unilateral cerebral palsy after perinatal stroke. The project has three parts: translation and cultural adaptation of the original materials, a pilot randomized feasibility study comparing eTIPS with usual care, and a qualitative study exploring family experiences, barriers, and facilitators to using the program at home.

In the first part, the study team will translate and culturally adapt the eTIPS materials for Spanish-speaking families, review them with experts, and test whether the content is clear, relevant, and usable. In the second part, families with infants diagnosed with perinatal stroke or at high risk of unilateral cerebral palsy will be assigned to either the eTIPS program or usual clinical care to assess recruitment, retention, adherence, safety, acceptability, and preliminary effects on infant motor development and family outcomes. In the third part, caregivers in the intervention group will take part in interviews to better understand how the program fits into daily life and what could improve future implementation.

Aperçu de l'étude

Description détaillée

This is a mixed-methods study designed to translate, culturally adapt, and evaluate the Spanish version of eTIPS, an early, parent-delivered therapy program originally developed for infants with perinatal stroke and risk of unilateral cerebral palsy. The project follows a staged approach with three linked phases: Phase I, translation and cross-cultural adaptation of the intervention materials; Phase II, a pilot randomized feasibility study; and Phase III, a qualitative study of family experiences and implementation.

Phase I will include forward translation, back-translation, expert review, and feedback from caregivers and professionals to ensure semantic, conceptual, and cultural equivalence of the Spanish materials. Phase II will randomize eligible infants to eTIPS or usual care, with the intervention delivered by caregivers in the home environment and supported by the research team. Outcomes in this phase will focus on feasibility and process measures such as eligibility, recruitment, consent, retention, adherence, usability, safety, and fidelity, as well as exploratory infant and caregiver outcomes.

The infant assessments may include measures of hand function, motor development, neurological status, and stroke-related outcomes, while caregiver outcomes may include well-being, stress, competence, and bonding. Phase III will use semi-structured interviews and thematic analysis to explore how caregivers experience the intervention in everyday routines, including perceived benefits, barriers, facilitators, and suggestions for improvement. The results will be used to refine the Spanish eTIPS program and inform the design of a future definitive multicenter trial.

Type d'étude

Interventionnel

Inscription (Estimé)

20

Phase

  • N'est pas applicable

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Infants with confirmed unilateral perinatal stroke diagnosis by neuroimaging, identified within first 3 months of life
  • Age at recruitment ≤3 months postnatal (intervention starts when clinically stable, maximum term-equivalent age)
  • Written informed consent from parents/legal guardians

Exclusion Criteria:

  • Known progressive neurodegenerative disorder or severe medical comorbidity preventing participation (e.g., ventilation-dependent respiratory failure)
  • Extensive bilateral intracerebral lesion making lateralized intervention irrelevant
  • Concurrent participation in another clinical trial with interfering treatment

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: eTIPS Intervention
Participants assigned to this arm will receive the Spanish-adapted eTIPS program, a parent-delivered, home-based early intervention for infants with perinatal stroke or risk of unilateral cerebral palsy. Families will receive training, adapted materials, and ongoing support to integrate lateralized therapeutic activities into daily routines from enrollment until corrected age 6 months.
Parent-delivered, home-based early therapy for infants with perinatal stroke or risk of unilateral cerebral palsy. Families receive the Spanish-adapted eTIPS materials, training, and ongoing support to integrate lateralized therapeutic activities into daily routines from enrollment until corrected age 6 months. The intervention is delivered alongside usual clinical care
Comparateur actif: Usual Care
Participants assigned to this arm will receive usual clinical care according to local practice, including standard neonatal, neurological, and rehabilitation follow-up. This arm serves as the comparator for feasibility, acceptability, and exploratory outcome assessment
Standard neonatal, neurological, and rehabilitation follow-up according to local clinical practice. Includes routine pediatric neurology monitoring, periodic neurological evaluations to track motor development and detect early signs of unilateral cerebral palsy, and referral to pediatric rehabilitation with physiotherapy sessions (1 session/week or biweekly, 30-45 minutes) focused on mobilizations, muscle tone control, joint range maintenance, general sensory stimulation, and basic postural guidelines.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Recruitment Rate
Délai: From identification to enrollment (baseline)
Proportion of eligible infants identified in neonatology/pediatric neurology who accept participation. Success criterion: ≥70% acceptance rate
From identification to enrollment (baseline)
Retention Rate
Délai: 6 months (end of intervention)
Percentage of families completing the 6-month follow-up. Success criterion: ≥80% retention
6 months (end of intervention)
Adherence Rate
Délai: Daily/weekly during 6 months
Days per week and minutes per week of practice recorded in digital diary/app. Success criterion: ≥70% practice days
Daily/weekly during 6 months

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Usability (SUS Score)
Délai: Post-intervention (6 months)
System Usability Scale (SUS) score for materials and platform. Target: ≥70 points
Post-intervention (6 months)
Safety
Délai: Throughout 6 months
Adverse events or incidents related to intervention (excessive fatigue, persistent rejection, feeding worsening)
Throughout 6 months
Parental Satisfaction
Délai: Post-Intervention (6 months)
Likert-scale questionnaire on experience, confidence gained, and recommendation of program
Post-Intervention (6 months)
Fidelity
Délai: Monthly during 6 months
Professional observation of correct eTIPS technique application during scheduled visits
Monthly during 6 months

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Hand Assessment for Infants (HAI)
Délai: Baseline, 3 months, 6 months, 12 months
Video-based observational assessment of unimanual and bimanual hand function
Baseline, 3 months, 6 months, 12 months
Infant Motor Profile (IMP)
Délai: Baseline, 3 months, 6 months
Structured observation of fine and gross motor patterns
Baseline, 3 months, 6 months
Paediatric Stroke Outcome Measure (PSOM)
Délai: Baseline, 3 months, 6 months
Neurological and functional sequelae monitoring post-stroke
Baseline, 3 months, 6 months
Bayley Scales of Infant Development (BSID-IV)
Délai: Baseline, 3 months, 6 months, 12 months
Standardized assessment of cognitive, motor and socio-emotional development in children from 1 to 42 months.
Baseline, 3 months, 6 months, 12 months
Hammersmith Infant Neurological Examination (HINE)
Délai: Baseline, 3 months, 6 months
Standardized neurological assessment for infants 2-24 months evaluating motor and neurological development
Baseline, 3 months, 6 months
Parenting Sense of Competence (PSOC)
Délai: Baseline, 3 months, 6 months
Questionnaire measuring parental perception of competence in child care and education
Baseline, 3 months, 6 months
Warwick-Edinburgh Mental Well-Being Scale (WEMWBS)
Délai: Baseline, 3 months, 6 months
Brief scale measuring psychological and emotional well-being in primary caregivers
Baseline, 3 months, 6 months
Family Empowerment Scale
Délai: Baseline, 6 months
Measures family perception of empowerment in caring for and supporting child with special needs
Baseline, 6 months
Edinburgh Postnatal Depression Scale (EPDS)
Délai: Baseline, 3 months, 6 months
10-item self-report screening for postpartum depressive symptoms (cut-off ≥10/12). Spanish validated
Baseline, 3 months, 6 months
Parenting Stress Index - Short Form (PSI-SF)
Délai: Baseline, 3 months, 6 months
36-item measure of parental stress across 3 subscales: Parental Distress, Parent-Child Dysfunctional Interaction, Difficult Child
Baseline, 3 months, 6 months
Postpartum Bonding Questionnaire (PBQ)
Délai: Baseline, 3 months, 6 months
25-item questionnaire assessing mother-infant bonding quality. Detects rejection, anger, infantification (cut-off ≥12 factor 1)
Baseline, 3 months, 6 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 septembre 2026

Achèvement primaire (Estimé)

31 juillet 2028

Achèvement de l'étude (Estimé)

31 décembre 2028

Dates d'inscription aux études

Première soumission

18 mai 2026

Première soumission répondant aux critères de contrôle qualité

18 mai 2026

Première publication (Réel)

26 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

26 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

18 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • Spanish eTIPS

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

No plan to share individual participant data (IPD). Data will be stored securely at Universidad de Castilla-La Mancha following Spanish and EU data protection regulations (RGPD/LOPDGDD). Aggregate results will be published in peer-reviewed journals.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner